Boeing Q1 earnings beat, 737 MAX ramp, MAX 7/10 certification breakthrough; competitive moves from Airbus; supply chain risk; CEO defers next narrowbody; T-7 Red Hawk airworthiness risk; Q2 earnings date July 28; EU tariff extension; MD-11 crash liability deepens; MQ-28 Ghost Bat operational milestone; insider buying and institutional moves; stock rallies on China Southern 777-8F order; Trump backs India-Boeing deal; Air India deferral signals backlog reallocation
Key Questions
What were Boeing's Q1 earnings results?
Boeing reported Q1 revenue growth of 14% with an EPS beat on estimates. The company is targeting a return to profitability in FY2025 with projected revenue of $89.5B and net income of $2.2B.
How is Boeing progressing with 737 MAX production and certification?
Production is accelerating to 47 aircraft per month with plans to reach 52 per month next year via a new Everett line. The MAX 7/10 program cleared a major FAA/EASA certification hurdle, with over 1,700 orders pending, and completed extreme crosswind autoland testing for the MAX 10.
What competitive actions is Airbus taking against Boeing?
Airbus is doubling A320neo capacity, accelerating the A220-500 program, and expanding its China supplier network. These moves aim to challenge Boeing's narrowbody dominance amid ongoing supply chain pressures.
What risks were identified with the T-7 Red Hawk program?
An investigation revealed severe airworthiness risks affecting the first 82 aircraft. This adds to broader defense program challenges for Boeing.
What is the status of the MD-11 crash investigation and Boeing's liability?
New reports show Boeing informed UPS that an engine mount flaw was not a flight safety risk prior to the fatal crash that killed 15. UPS stated it relied on this guidance and skipped enhanced inspections, deepening potential liability exposure.
What institutional and insider trading activity occurred with Boeing stock?
Keybank National Association increased its stake by 727% with 214,200 shares, while Strs Ohio reduced its position by 9.7%. Director Tilden bought shares at $218.50, though other insider selling was mixed.
When is Boeing's Q2 earnings release and what are analyst expectations?
Q2 earnings are scheduled for July 28 with consensus estimates at EPS of -$0.25 and revenue of $23.92B. The Farnborough Airshow in July is viewed as a near-term catalyst for orders.
What political or trade developments are supporting Boeing?
President Trump is personally backing a new India-Boeing deal, providing potential tailwinds for export orders. The EU also extended its zero-tariff agreement on U.S. aircraft parts.
Q1 results top estimates: revenue +14%, EPS beat. 737 MAX production accelerating to 47/month, targeting 52/mo next year with new Everett line. MAX 7/10 cleared biggest certification hurdle—FAA/EASA say when not if, 1,700+ orders waiting. MAX 10 autoland crosswind testing completed, a small but positive certification milestone. Airbus doubles A320neo capacity, accelerates A220-500, and expands China supplier network. CEO Ortberg defers next narrowbody. T-7 Red Hawk investigation reveals severe airworthiness risks on first 82 aircraft. Fitch upgrades Boeing outlook to Positive, affirms BBB-. New AP report confirms Boeing told UPS an MD-11 engine mount flaw wasn't a flight safety risk before fatal crash killed 15; UPS now says Boeing's guidance led them to skip enhanced inspections, deepening safety liability narrative. MQ-28 Ghost Bat achieved operational milestone during Valiant Shield exercise, integrating with US forces—positive for Boeing's CCA positioning. Q2 earnings scheduled July 28 (consensus EPS -$0.25, rev $23.92B). Farnborough Airshow (July 20) is a near-term catalyst for orders and competitive positioning. FY2025 financials: $89.5B revenue, $2.2B net income, return to profitability, Spirit integration, negative FCF, high debt. Stock up 3.5% on June delivery recovery (60 planes), and rallied on China Southern 777-8F order (July 31). Insider selling mixed. Director Tilden bought shares at $218.50; Cane Capital cut 23.9% position – mixed insider signals. Keybank National Association boosted stake by 727% (214,200 shares) – positive institutional signal. Strs Ohio sold 50,145 shares (9.7% cut) – minor negative. Trump personally backing a Boeing-India deal (no specifics yet) adds positive political tailwind for export orders. Air India deferral (Etihad/Saudia absorbing slots) signals backlog reallocation from weak to strong hands – demand-side risk for widebody backlog. Iran market not a near-term catalyst due to backlogs and engine shortages.